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Background: Previous studies have suggested a probable association between the polymorphism of a
microsatellite locus located in the promoter of IGF1 (Insulin-like growth factor 1) gene and the serum level of IGF1,
as well as many age-related diseases. Based on these results, we hypothesized that this polymorphism may
influence longevity in humans. We performed an association study in a Han Chinese population to test this
hypothesis.
Findings: We recruited 493 elderly Han Chinese individuals (females ≥ 94; males ≥ 90) and 425 young individuals
(controls) from Dujiangyan (Sichuan province, China). The genotype distributions and allele frequencies of the
microsatellite site in the elderly and control groups were compared by chi square test.
Our results suggested that there was no association between the microsatellite polymorphism and longevity in our
Han Chinese population. However, there were more male persons with 18/21 genotype in elderly group than that
in control group (11.11 vs. 5.45%, p = 0.011). As the difference was not significant when corrected by Bonferroni
method, we speculate that the 18/21 genotype can not be functional in longevity; however, it may link with the
real functional loci as there is a long haplotype block embracing the microsatellite locus.
Conclusions: There was no association between polymorphism of the microsatellite in promoter of IGF1 gene and
longevity in our study. Future association studies containing the long haplotype block are deserved and can test
our speculation of the potential linkage of 18/21 genotype and functional loci.
Background
IGF1 (Insulin-like growth factor 1) plays a number of
important roles in the human body. It is involved in
physiological processes such as growth, development,
and metabolism [1], and has been implicated as a factor
in the development of common diseases [2]. Meanwhile,
a conserved insulin/IGF1 signal pathway which may
affect ageing and longevity is known in E.coli, yeast, dro-
sophila, mice and humans [3-7]. Elucidating the func-
tions of insulin/IGF1 pathway in ageing and longevity is
a current hot spot in longevity research [8].
Serum IGF1 levels appear to influence susceptibility to
disease, and therefore longevity. For example, people
with a high level of circulating IGF1 are more suscepti-
ble to cancers, while a low level of circulating IGF1 is a
risk factor for cardiovascular diseases, premature athero-
genesis, and diabetes [5]. Furthermore, Yang et al. sug-
gested that in humans, a reduced level of serum IGF1 in
early adulthood and an increased level in elderly time
might be a predictor of high longevity. Meanwhile, the
heritability of individual IGF1 level variation is about
50% [9], which implies that IGF1 regulation is geneti-
cally determined. Considering the evidence for heritabil-
ity of longevity [10], perhaps there is a hereditable shift
in IGF1 regulation in long-lived people [8].
A cytosine-adenine (CA) repeat polymorphism in
IGF1 gene promoter region (1 kilo base pairs upstream
from the transcription start site) [11] has been asso-
ciated with serum IGF1 level [12,13]. At the same time,
many studies have related this microsatellite polymorph-
ism to age-related diseases such as diabetes, cancers,
and cardiovascular diseases [14-19]. These results are
disputed by several other studies [9,20-24]. However,
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potential functional site for serum IGF1 level regulation,
and might therefore function in ageing and longevity.
Therefore, exploring the association of this microsatel-
lite polymorphism and longevity is urgent.
To our knowledge there have been no reports on the
association between the microsatellite polymorphism
and longevity in the Han Chinese people. In this study,
we conducted an association study in a Han Chinese
population to investigate the potential function of this
microsatellite locus in predicting longevity.
Methods
Subjects
A total of 493 elderly individuals (females ≥ 94 years
old; males ≥ 90 years old) from Dujiangyan (Sichuan
province, China) agreed to participate in this study.
Ages were authenticated by the official certification of
the Fifth Nation Census in China as well as by the infer-
ence of the number of generations, and the memories of
these, their offspring and other local elderly people. The
age was confirmed when the certification and the infer-
ence were consistent. We also recruited 425 healthy,
local individuals between the ages of 32 - 73 years to act
as a control group. This control group included 110
spouses of the children of the elderly participants. The
subjects’ information is listed in Table 1.
All participants indicated informed consent by signing
a form after they had been given a clear explanation of
the potential risks of the study. This research was
approved by the Ethics Committee on human experi-
mentation of Kunming Institute of Zoology, Chinese
Academy of Sciences and relevant bodies in Dujiangyan.
The study was done in accordance with the Declaration
of Helsinki and subsequent amendments.
Genotyping
DNA was extracted from white blood cells in whole
blood by the standard phenol/chloroform method. Pri-
mers for PCR followed those used in previous study
[21]. The forward primer was labeled at the 5’-end with
6-FAM fluorescent dye. PCR reactions each included 20
ng genomic DNA as template, 2.5 μL 10× PCR buffer,
1.0 μL dNTP (2.5 mmol·L
-1), 0.5 μLB S A( b o v i n es e r u m
albumin, 200 μg·ml
-1), 0.5 μLf o r w a r dp r i m e r( 1 0
pmol·μL
-1), 0.5 μL reverse primer (10 pmol·μL
-1), 0.125
μL rTaq polymerase (Takara, Dalian, China) and dis-
tilled water to a total volume of 25 microliter (μL).
Thermocycling parameters included an initial denatura-
tion of 5 min. at 95°C; 35 cycles of: 95°C for 30 s, 62°C
for 1 min. and 72°C for 1 min.; and a final extension at
72°C for 10 min. PCR products were denatured and size
fractionated on 6% denaturing polyacrylamide gel run
on an ABI 3730 automated sequencer (AppliedBiosys-
tems, Foster City, CA). Alleles were read and scored by
GeneMapper V4.0 software (ABI Perkin Elmer) using
Liz500 as size standard. Alleles were verified artificially
twice by two different persons. The number of repeats
contained in alleles of different length was confirmed by
cloning and sequencing two differently sized PCR pro-
ducts (ie. two alleles). We replicated PCR amplication
and genotyping of 30% of the samples, ensuring that
replicates were performed by a different researcher.
Ambiguous results were confirmed by another PCR and
fragment analysis.
Statistical analysis
A test of Hardy Weinberg Equilibrium (HWE) was per-
formed using Genepop 3.4 [25]. The program PHASE
v2.1 [26,27] was used to estimate the haplotype of each
individual. Statistical analyses were performed with SPSS
(version 13.0, Chicago, IL). Allele distributions and gen-
otype frequencies of the elderly (test) and young (con-
trol) groups were compared with Pearson’s chi square
test, using a two-tailed p value was and considering p
<0.05 to be significant. We used a Bonferroni correction
to correct for multiple tests of the same data.
To explore the potential function of this microsatellite
locus, we categorized the whole population into three
genotype groups depending on owning 2, 1, or no
copies of major alleles (19- and 21-repeat): 19/19 (21/
21), 19/non (21/non), and non/non. We performed chi
square test to compare 1) each genotype to the sum of
the other two, 2) the frequencies of three genotypes,
and 3) the distribution of major allele (19(21)-allele vs.
non) in elderly and control groups in order to detect
any potential functions of the major alleles.
Results
In this study, we examined the microsatellite poly-
morphism in IGF1 gene promoter in 493 elderly indivi-
duals (241 females and 252 males) and 425 control
individuals (223 females and 202 males). The length
range of the microsatellite locus was 17 to 23 repeats
(only one person has a 13-repeat allele), and the most
common alleles are 19-repeat (39.12%) and 21-repeat
Table 1 Demographics of the study participants
Group N (Male/Female) Age (Mean ± SD, years) Nationality Range of age (year)
Elderly 493 (252/241) 94.97 ± 3.15 Han Male ≥ 90; Female ≥ 94
Control 425 (202/223) 57.17 ± 9.21 Han 32-73
Xie et al. BMC Research Notes 2010, 3:55
http://www.biomedcentral.com/1756-0500/3/55
Page 2 of 6(26.14%). The genotype distribution followed Hardy-
Weinberg Equilibrium (HWE) in both elderly and
control groups, as well as when stratified by gender
(p > 0.05).
All alleles and their frequencies are listed in Table 2.
Allele frequencies of elderly and control groups were
not significantly different (p = 0.922, df = 9), even when
stratified by gender. The results of comparison of the
distribution of common alleles (19- and 21-repeat) in
both groups are listed in Table 3. There were no signifi-
cant differences in genotype distribution and allele
f r e q u e n c i e si nt h et w og r o u p sc o n s i d e r e da saw h o l e .
However, when we stratified the groups by gender, there
were more individuals with genotype 21/non (21-repeat/
non-21-repeat) in the male elderly group than in the
male control group (42.06 vs. 32.18%, p = 0.031). After
Bonferroni correction, the result was no longer
significant.
To investigate potential causes of the different fre-
quencies of the genotype 21/non in male participants,
we compared the distributions of all possible genotypes
in the male elderly and male control groups. Altogether,
Table 2 Allele frequencies of the microsatellite in sampled elderly and control groups.
Allele
1 All Women Men
Elderly(%) Control(%) Elderly(%) Control(%) Elderly(%) Control(%)
13 1(0.10) 0 1(0.21) 0 0 0
16 1(0.10) 1(0.12) 0 1(0.22) 1(0.20) 0
17 79(8.01) 68(8.00) 37(7.68) 34(7.62) 42(8.33) 34(8.42)
18 169(17.14) 138(16.24) 80(16.60) 71(15.92) 89(17.66) 67(16.58)
19 380(38.54) 338(39.76) 198(41.08) 173(38.79) 182(36.11) 165(40.84)
20 69(7.00) 54(6.35) 29(6.02) 28(6.28) 40(7.94) 26(6.44)
21 260(26.37) 220(25.88) 124(25.73) 121(27.13) 136(26.98) 99(24.51)
22 23(2.33) 28(3.29) 12(2.49) 15(3.36) 11(2.18) 13(3.22)
23 4(0.41) 2(0.24) 1(0.21) 2(0.45) 3(0.60) 0
24 0 1(0.12) 0 1(0.22) 0 0
p = 0.922 p = 0.948 p = 0.455
1. The number for an allele is the amount of repeats of this allele.
Table 3 Chi square test results for the genotype distribution and allele frequencies of the 19- and 21-repeat alleles in
elderly and control groups.
All Women Men
Elderly(%) Control(%) P value Elderly(%) Control(%) P value Elderly(%) Control(%) P value
Genotype
19-repeat
1 0.543 0.582 0.283
19/19
2 69(14.00) 70(16.47) 0.297 36(14.94) 33(14.80) 0.966 33(13.10) 37(18.32) 0.126
19/non
2 242(49.09) 198(46.59) 0.45 126(52.28) 107(47.98) 0.355 116(46.03) 91(45.05) 0.835
non/non
2 182(36.92) 157(36.94) 0.994 79(32.78) 83(37.22) 0.316 103(40.87) 74(36.63) 0.357
Allele
19-repeat
3 380(38.54) 338(39.76) 0.592 198(41.08) 173(38.79) 0.477 182(36.11) 165(40.84) 0.145
non 606(61.46) 512(60.24) 284(58.92) 273(61.21) 322(63.89) 239(59.16)
Genotype
21-repeat
4 0.31 0.88 0.082
21/21
2 30(6.09) 33(7.76) 0.316 15(6.22) 16(7.17) 0.682 15(5.95) 17(8.42) 0.308
21/non
2 200(40.57) 154(36.24) 0.179 94(39.00) 89(39.91) 0.842 106(42.06) 65(32.18) 0.031
6
non/non
2 263(53.35) 238(56.00) 0.421 132(54.77) 118(52.91) 0.688 131(51.98) 120(59.41) 0.114
Allele
21-repeat
5 260(26.37) 220(25.88) 0.813 124(25.73) 121(27.13) 0.628 136(26.98) 99(24.50) 0.397
Non 726(73.63) 630(74.12) 358(74.27) 325(72.87) 368(73.02) 305(75.50)
1. P values were obtained by the chi-square test of whole genotype distribution categorized by 19-repeat allele.
2. P values were obtained by the chi-square test of genotype distribution categorized by each genotype.
3. P values were obtained by the chi-square test of allele frequencies categorized by 19-repeat allele.
4. P values were obtained by the chi-square test of whole genotype distribution categorized by 21-repeat allele.
5. P values were obtained by the chi-square test of allele frequencies categorized by 21-repeat allele.
6. After Bonferroni correction, p < 0.0017 is considered significant.
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21 repeats: 17/21, 18/21, 19/21, 20/21, 21/22, and 21/23
(The number represents how many repeats there is in
the microsatellite locus in this genotype). A chi square
test showed a significant difference in the distribution of
the 18/21 genotype in male elderly and male control
groups (11.11 vs. 5.45%, p = 0.011; Table 4). After Bon-
feronni correction for multiple tests, the result was no
longer significant.
In a previous study of the same population [28], we
reported no association between longevity and the three
SNPs (rs2288377, rs5742612, and rs35767) surrounding
the microsatellite. Combining the two datasets, we
constructed the haplotype of each individual for the
microsatellite locus and these three SNPs. The result is
listed in Table 5. There are 18 different haplotypes in
the population and no significant result was obtained in
this study.
Discussion
In the present study, we explored the association of a
microsatellite polymorphism in IGF1 gene promoter
with longevity in a Han Chinese population. The elderly
a n dc o n t r o lg r o u p sw e r er e c r u i t e df r o mt h es a m ea r e a .
They shared the same living conditions, diet habits, and
culture. This allows us to exclude non-genetic factors
which may also affect longevity, and ensures that popu-
lation stratification can be avoided to a certain extent in
our study [29]. Additionally, the genotype distributions
of both groups did not deviate from HWE.
To our knowledge, this is the first study of the corre-
lation between this microsatellite polymorphism and
longevity in a Han Chinese population. The allele distri-
bution of this microsatellite in our population is consis-
tent with a previous study on breast cancer in Chinese
people [17]. The distribution is different from that in
Table 4 The comparison of genotypes with one 21-repeat







3/21 14(5.56) 11(5.45) 0.716
18/21 28(11.11) 11(5.45) 0.011
4
19/21 42(16.67) 34(16.83) 0.591
20/21 14(5.56) 7(3.47) 0.182
21/22 7(2.78) 2(0.99) 0.18
21/23 1(0.40) 0
1. The percentage was obtained from dividing the amounts of people in each
category by the total number of people of the respective group including all
genotypes.
2. P values were obtained by the chi-square test of genotype distribution
categorized by each genotype in respective group.
3. The number represents how many repeats there is in the microsatellite
locus in this genotype.
4. The new cutoff p-value is 0.0083.
Table 5 The comparison of haplotype distribution in elderly and control groups.
All Female Male
Haplotype Elderly(%) Control(%) Elderly(%) Control(%) Elderly(%) Control(%)
C1 3
1 TT 1(0.10) 0 1(0.21) 0 0 0
C 16 TT 0 1(0.12) 0 1(0.23) 0 0
C 17 TT 78(7.99) 68(8.46) 37(7.71) 34(7.91) 41(8.27) 34(9.09)
C 18 TT 162(16.59) 125(15.55) 74(15.42) 66(15.35) 88(17.74) 59(15.78)
C 19 TT 357(36.58) 295(36.69) 186(38.75) 150(34.88) 171(34.48) 145(38.77)
C 19 CA 1(0.10) 0 0 0 1(0.20) 0
C 20 TT 28(2.87) 21(2.61) 13(2.71) 12(2.79) 15(3.02) 9(2.41)
C 21 TT 10(1.02) 8(1.00) 1(0.21) 3(0.70) 9(1.81) 5(1.34)
T 18 CA 8(0.82) 3(0.37) 6(1.25) 2(0.47) 2(0.40) 1(0.27)
T 19 TT 12(1.23) 8(1.00) 8(1.67) 5(1.16) 4(0.81) 3(0.80)
T 19 CA 5(0.51) 16(1.99) 2(0.42) 11(2.56) 3(0.60) 5(1.34)
T 20 TT 29(2.97) 22(2.74) 12(2.50) 12(2.79) 17(3.43) 10(2.67)
T 20 CA 10(1.02) 7(0.87) 4(0.83) 3(0.70) 6(1.21) 4(1.07)
T 21 TT 6(0.61) 10(1.24) 2(0.42) 8(1.86) 4(0.81) 2(0.53)
T 21 CA 242(24.80) 186(23.13) 121(25.21) 103(23.95) 121(24.40) 83(22.19)
T 22 CA 23(2.36) 28(3.48) 12(2.50) 15(3.49) 11(2.22) 13(3.48)
T 23 CA 4(0.41) 4(0.50) 1(0.21) 4(0.93) 3(0.60) 0
T 24 CA 0 2(0.25) 0 1(0.23) 0 1(0.27)
Total
2 976 804 480 430 496 374
P-value 0.260 0.142 0.797
1. The number represents how many repeats there is in the microsatellite locus in this haplotype.
2. The total amounts are less than the whole numbers of the population individuals because there are missing data in SNPs dataset.
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[13], demonstrating that allele frequencies at this locus
differ between the two populations. This difference may
b ec a u s e db yd e m o g r a p h i cg e o g r a p h ya n dh i s t o r yo f
Chinese and Caucasian populations, or by genetic drift.
However, within the Han population there is no signifi-
cant difference in genotypes between elderly and control
groups, even when stratified by gender. Our results sug-
gest that no specific alleles at this locus are associated
with longevity in this Han population.
To explore the potential role of the microsatellite
locus, we compared the genotype frequencies in elderly
and control groups depending on 19-repeat and 21-
repeat (the two most common alleles) to define
categories. As stated in the introduction, the common
19-repeat allele is thought to be related to serum IGF1
levels and many age-related diseases, although the
results are equivocal. The contradiction between studies
can be explained by different population size, different
ethnicities in different studies, and small effect of this
polymorphism in complex diseases. Similarly, longevity
is a complex trait, influenced by the additive effects of
many genetic variations (not to mention stochasticity).
Thus an association study may simply not have suffi-
cient power to detect significant correlations between
the 19-repeat and longevity.
We initially found a significant difference between the
21-repeat/non genotype frequencies in male elderly
(42.06%) and control (32.18%) groups, as well as
between the 18/21 genotype (11.11 versus 5.45%, p =
0.011) and other genotypes. However, Bonferroni cor-
rections increased the p values past the cut-off point for
statistical significance. Based on these results, the 21-
repeat can not be a potential functional allele for male
longevity. The 18/21 genotype may still be linked to real
functional variations, because in a recent study, a long
haplotype block including this microsatellite region was
reported [30]. We constructed haplotypes for each parti-
cipant using our microsatellite and three SNPs data, and
found that no single haplotype was positively associated
with longevity. The haplotype block is long enough that
more SNPs from this region could be included for test-
ing if a potential functional site exists, and we recom-
mend this approach be used before our initial
hypothesis is fully rejected., in order to ensure that
small sample size (of loci) did not bias the results.
In summary, the results from the present research
suggest no association between the microsatellite poly-
morphism in IGF1 gene promoter and longevity in a
Han Chinese population. The possibility of a functional
site linked to the microsatellite locus (especially in men)
deserves future studies.
Conclusions
In this study, no association was discovered between the
microsatellite site in IGF1 gene promoter and longevity
in a Han Chinese population. In males, the 18/21 geno-
type was more frequent in the elderly group than in the
control group (11.11 vs. 5.45%, p = 0.011). Future stu-
dies including an increased sample size and more loci in
the long haplotype block will enable us to test the
hypothesized linkage between the 18/21 genotype and
functional loci.
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